M&A Deal Summary |
|
|---|---|
| Date | 2014-12-17 |
| Target | Evolva Holding - EV-035 |
| Sector | Life Science |
| Buyer(s) | Emergent BioSolutions |
| Sellers(s) | Evolva |
| Deal Type | Divestiture |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1998 |
| Sector | Healthcare Services |
| Employees | 900 |
| Revenue | 1.0B USD (2024) |
Emergent BioSolutions is a specialty biopharmaceutical company seeking to protect and enhance life by offering specialized products to healthcare providers and governments to address medical needs and emerging health threats. Emergent BioSolutions was founded in 1998 and is based in Gaithersburg, Maryland.
| DEAL STATS | # |
|---|---|
| Overall | 8 of 11 |
| Sector: Life Science M&A | 5 of 7 |
| Type: Divestiture M&A Deals | 5 of 6 |
| Country: Switzerland M&A | 1 of 1 |
| Year: 2014 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-02-21 |
Cangene
Winnipeg, Manitoba, Canada Cangene Corporation is a biopharmaceutical company focused on the development and commercialization of specialty therapeutics, primarily targeting biodefense applications as well as infectious disease, hematology and transplantation. |
Buy | $222M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-05-28 |
Emergent BioSolutions - Plasma Collection Facility
Winnipeg, Manitoba, Canada Emergent’s plasma collection center is an FDA and Health Canada licensed plasma collection facility. The plasma collection center is conveniently located in close proximity to the existing Emergent Winnipeg based cGMP manufacturing facility, which was recently announced as providing ProMetic with up to 250,000 liters of annual plasma processing capacity. |
Sell | - |
| Category | Company |
|---|---|
| Founded | 2004 |
| Sector | Life Science |
| Employees | 65 |
| Revenue | 9M CHF (2023) |
Evolva is a provider of biosynthetic and evolutionary technologies to create and optimize small molecule compounds and their production routes. Evolva Holding was incorporated in 2004 and is based in Reinach, Switzerland.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: Switzerland M&A | 1 of 1 |
| Year: 2014 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-12-16 |
Allylix
San Diego, California, United States Allylix, Inc. is a renewable chemicals company that develops terpene products and their derivatives for the flavor and fragrance, food ingredient, pharmaceutical, agricultural and biofuel markets. |
Buy | $46M |
